A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

November 5, 2018

Study Completion Date

April 30, 2019

Conditions
Pain
Interventions
DRUG

Felbinac Trometamol Injection

Felbinac Trometamol Injection will be infused IV in 100 mL normal saline,in a 30-minute period using a programmable pump.Three days after the single dose,the drug was given 7 times,3 times/day,once every 8 hours. It means the drug was given 3 times on D3 and D4,once on D5.

DRUG

Placebos

Normal saline will be infused IV in 100 mL normal saline,in a 30-minute period using a programmable pump.Three days after the single dose,the Placebo was given 7 times,3 times/day,once every 8 hours.It means the Placebo was given 3 times on D3 and D4,once on D5.

Trial Locations (1)

130021

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Shijiazhuang Yiling Pharmaceutical Co. Ltd

INDUSTRY

NCT03617510 - A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China | Biotech Hunter | Biotech Hunter